Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials
AbbVie
Geert D'Haens; Remo Panaccione; Filip Baert; Peter Bossuyt; Jean-Frederic Colombel; Silvio Danese; Marla Dubinsky; Brian G Feagan; Tadakazu Hisamatsu; Allen Lim; James O Lindsay; Edward V Loftus; Julian Panés; Laurent Peyrin-Biroulet; Zhihua Ran; David T Rubin; William J Sandborn; Stefan Schreiber; Ezequiel Neimark; Alexandra Song; Kristina Kligys; Yinuo Pang; Valerie Pivorunas; Sofie Berg; W Rachel Duan; Bidan Huang; Jasmina Kalabic; Xiaomei Liao; Anne Robinson; Kori Wallace; Marc Ferrante